Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinomas of the Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00030498
What this trial is testing

Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+83 more
National Cancer Institute (NCI) 75
Early research (Phase 1)Ended earlyNCT01192763
What this trial is testing

RO4929097 Before Surgery in Treating Patients With Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasStage IA Pancreatic CancerStage IB Pancreatic Cancer+2 more
National Cancer Institute (NCI) 30
Not applicableApproved For MarketingNCT03906331
What this trial is testing

Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation

Who this might be right for
Non Small Cell Lung CancerMedullary Thyroid CancerColon Cancer+4 more
Eli Lilly and Company
Testing effectiveness (Phase 2)Looking for participantsNCT07148128
What this trial is testing

Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.

Who this might be right for
Advanced or Metastatic KRAS-mutant Tumor in Pancreatic AdenocarcinomaAdvanced or Metastatic KRAS-mutant Tumor in Colorectal CancerAdvanced or Metastatic KRAS-mutant Tumor in Non Small Cell Lung Cancer+2 more
Auricula Biosciences Inc.
Early research (Phase 1)Study completedNCT02009449
What this trial is testing

Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors

Who this might be right for
MelanomaProstate CancerOvarian Cancer+6 more
Eli Lilly and Company 353
Testing effectiveness (Phase 2)Looking for participantsNCT05482893
What this trial is testing

Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)

Who this might be right for
Gastric or Gastroesophageal Junction AdenocarcinomaPancreatic Ductal AdenocarcinomaBiliary Tract Cancer (BTC)
Phanes Therapeutics 258
Testing effectiveness (Phase 2)Ended earlyNCT01240304
What this trial is testing

A Phase II Study to Assess the Efficacy and Safety of Preoperative Chemo With Radiation Therapy for Patients With Borderline Unresectable Adenocarcinoma of the Pancreas

Who this might be right for
Pancreatic Cancer
University of Arkansas 10
Testing effectiveness (Phase 2)Study completedNCT00101348
What this trial is testing

Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+64 more
National Cancer Institute (NCI) 66
Testing effectiveness (Phase 2)Looking for participantsNCT06782932
What this trial is testing

Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 38
Not applicableEnrolling By InvitationNCT06276764
What this trial is testing

The LINFU® U.S. Registry in Patients With IPMN (Intraductal Papillary Mucinous Neoplasm of the Pancreas)

Who this might be right for
IPMN, PancreaticPancreas CancerPancreatic Cyst
Adenocyte, LLC 500
Testing effectiveness (Phase 2)Study completedNCT02562898
What this trial is testing

Ibrutinib Combined With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Adenocarcinoma
Margaret Tempero 18
Testing effectiveness (Phase 2)Looking for participantsNCT04990609
What this trial is testing

EUS-RFA PANCARDINAL-1 Trial

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)
The University of Texas Health Science Center, Houston 60
Testing effectiveness (Phase 2)Study completedNCT00923299
What this trial is testing

Cetuximab and Trastuzumab in Treating Patients With Metastatic Pancreatic Cancer That Progressed After Previous Treatment With Gemcitabine

Who this might be right for
Pancreatic Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 33
Testing effectiveness (Phase 2)Study completedNCT00260364
What this trial is testing

Combining Erlotinib Plus Bevacizumab and Gemcitabine Plus Capecitabine to Treat Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Royal Marsden NHS Foundation Trust 44
Early research (Phase 1)Study completedNCT00544193
What this trial is testing

Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerGastric Cancer+2 more
City of Hope Medical Center 16
Testing effectiveness (Phase 2)Study completedNCT00059826
What this trial is testing

Adjuvant Chemoradiotherapy and Interferon Alfa in Treating Patients With Resected Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Alliance for Clinical Trials in Oncology 89
Early research (Phase 1)Study completedNCT00462553
What this trial is testing

Sunitinib and Gemcitabine in Treating Patients With Pancreatic Cancer or Other Solid Tumors

Who this might be right for
Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage III Pancreatic Cancer+2 more
National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Looking for participantsNCT06472388
What this trial is testing

Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors

Who this might be right for
Neuroendocrine TumorsProgressionNeuroendocrine Tumor Grade 1+4 more
AC Camargo Cancer Center 100
Testing effectiveness (Phase 2)Looking for participantsNCT06825546
What this trial is testing

Icaritin in Combination With AG in Patients With Previously Untreated Advanced Pancreatic Ductal Adenocarcinoma

Who this might be right for
Advanced Pancreatic Ductal Adenocarcinoma
Sir Run Run Shaw Hospital 70
Large-scale testing (Phase 3)Not Yet RecruitingNCT07803783
What this trial is testing

Compare the Efficacy and Safety of YL201 With Standard Chemotherapy in Patients With Metastatic Pancreatic Cancer After Failure of Gemcitabine-Based Systemic Chemotherapy

Who this might be right for
Metastatic Pancreatic CancerPancreatic Ductal Adenocarcinoma (PDAC)
MediLink Therapeutics (Suzhou) Co., Ltd. 320
Next Page
110